Drug
dabrafenib
Marketed as TAFINLAR.
Generic name
dabrafenib
Brand names
TAFINLAR
First FDA approval
2013-05-29
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA217514 | TAFINLAR | 2023-03-16 | NOVARTIS |
| NDA202806 | TAFINLAR | 2013-05-29 | NOVARTIS |
Manufacturers
NOVARTIS
Frequently asked questions
When was dabrafenib FDA approved?
Earliest FDA approval on record: 2013-05-29.
What brand names are sold as dabrafenib?
TAFINLAR.
Sources
Appeal a dabrafenib denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com